Otitis Media (OM) Withdrawn Phase 4 Trials for Ciprofloxacin (DB00537)

Also known as: Otitis Media / Ear infection / Otitis media NOS / Middle ear infection / Unspecified otitis media / Middle ear inflammation / Catarrh of middle ear

IndicationStatusPhase
DBCOND0059550 (Otitis Media (OM))Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00956748N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis MediaTreatment